HLC - Investor Profile and Portfolio

WuXi AppTec is a provider of a suite of CRO and CDMO services for small molecules, biologics, and medical devices. It offers a suite of services for the research, development, and manufacturing of both small molecules and biologics and also caters to medical device development and has operations all over the globe. They provide a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. The company built its initial capabilities around discovery chemistry and has further enhanced the integrated services with analytical services, bio-analytical services, process research, process development services, API manufacturing services, DMPK/ADME, discovery biology, pharmacology, formulation, toxicology, genomic services, biologics manufacturing services, antibody, and biological research reagent manufacturing and sales, and most recently clinical research and regulatory services. In 2022, the company recorded annual revenues of $5.84B and a net profit of $1.31B.

Pharmaron offers a suite of drug discovery and development services for small molecules, nucleosides, nucleotides, peptides, lipids and carbohydrates. They offer their R&D services across a number of disciplines including chemistry, biology, DMPK, pharmacology, toxicology and chemical and formulation development. The company claims that their chemistry division is one of the largest chemistry service providers in the world with experience and expertise in organic synthesis, library/high-throughput synthesis, chiral chemistry, medicinal, computational and cheminformatics, bioorganic chemistry, process and scale-up, analytical and purification. Their biologics division offers services such as antibody/protein engineering, antibody humanization, cell line development, recombinant antibody production, protein expression, purification, and characterization.The company has acquired Xceleron and SNBL CPC to augment its offerings.

Manufacturer of pharmaceutical formulations, active pharmaceutical ingredients, and veterinary drugs. The company develops and produces a range of pharmaceutical products, including formulations for human use and active pharmaceutical ingredients. It also offers products related to veterinary medicine. A robust research and development system supports innovation and quality control throughout the production process. The company maintains comprehensive production and quality systems.

Provider of asset management services. It offers services such as accounting, asset management, and real estate brokerage among others. It invests on behalf of corporate pension annuities, government entities, private and trust banks, and public pension funds.